Chemoinformaics analysis of 1-(Cyclohex-1-en-1-yl)piperidine
| Molecular Weight | 165.28 | nRot | 1 |
| Heavy Atom Molecular Weight | 146.128 | nRig | 12 |
| Exact Molecular Weight | 165.152 | nRing | 2 |
| Solubility: LogS | -3.014 | nHRing | 1 |
| Solubility: LogP | 3.215 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.1391 |
| nHD | 0 | BPOL | 20.7709 |
| QED | 0.577 |
| Synth | 2.392 |
| Natural Product Likeliness | -0.407 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.284 |
| Pgp-sub | 0.013 |
| HIA | 0.006 |
| CACO-2 | -4.642 |
| MDCK | 0.0000138 |
| BBB | 0.936 |
| PPB | 0.843248 |
| VDSS | 1.082 |
| FU | 0.247615 |
| CYP1A2-inh | 0.696 |
| CYP1A2-sub | 0.928 |
| CYP2c19-inh | 0.454 |
| CYP2c19-sub | 0.406 |
| CYP2c9-inh | 0.15 |
| CYP2c9-sub | 0.633 |
| CYP2d6-inh | 0.185 |
| CYP2d6-sub | 0.863 |
| CYP3a4-inh | 0.153 |
| CYP3a4-sub | 0.197 |
| CL | 7.504 |
| T12 | 0.554 |
| hERG | 0.062 |
| Ames | 0.008 |
| ROA | 0.065 |
| SkinSen | 0.96 |
| Carcinogencity | 0.528 |
| EI | 0.973 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.099 |
| Antiviral | No |
| Prediction | 0.771397 |